Trial Profile
Safety and Long-Term Efficacy of Transition from Sildenafil to Tadalafil due to Side Effects in Patients with Pulmonary Arterial Hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Nov 2015
Price :
$35
*
At a glance
- Drugs Tadalafil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Adverse reactions; Therapeutic Use
- 11 Nov 2015 New trial record